North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group.

A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract (2002) 4.37

Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate. BMJ (1999) 3.60

Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. Outcomes of Depression International Network (ODIN) Group. BMJ (2000) 2.22

When should clinical guidelines be updated? BMJ (2001) 1.70

Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project. Qual Health Care (2000) 1.26

Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract (2000) 0.89

Clinical oral examinations may not be predictive of dysplasia or oral squamous cell carcinoma. J Evid Based Dent Pract (2013) 0.78

Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial. Trials (2013) 0.77

Is untargeted educational outreach visiting delivered by pharmaceutical advisers effective in primary care? A pragmatic randomized controlled trial. Implement Sci (2007) 0.75

Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA (1999) 13.39

The use of statins: a case of misleading priorities? BMJ (1997) 13.35

Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2007) 7.25

Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2001) 7.24

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ (1993) 7.14

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2000) 6.67

Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev (2007) 6.02

beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (1999) 5.66

North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ (1998) 4.39

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ (2001) 4.21

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09

Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate. BMJ (1999) 3.60

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50

Promoting cost effective prescribing. BMJ (1995) 3.46

North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ (1998) 3.14

Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 3.04

Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78

North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ (1998) 2.72

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61

Something rotten in the state of clinical and economic evaluations? Health Econ (1994) 2.50

Developing valid guidelines: methodological and procedural issues from the North of England Evidence Based Guideline Development Project. Qual Health Care (1996) 2.49

Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 2.33

EUR-ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol Assess Health Care (1997) 2.18

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. BMJ (1998) 2.15

When is it cost-effective to change the behavior of health professionals? JAMA (2001) 2.08

Carcinogenic activity of bracken. Nature (1965) 2.03

How to develop cost-conscious guidelines. Health Technol Assess (2001) 2.03

The evidence for beta blockers in heart failure. BMJ (1999) 1.84

North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ (1998) 1.84

Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 1.79

Computer support for determining drug dose: systematic review and meta-analysis. BMJ (1999) 1.79

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75

Cost-effectiveness league tables: more harm than good? Soc Sci Med (1993) 1.74

Economics of treatment of depression. Br J Psychiatry (1995) 1.74

Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69

Cardiovascular safety of fexofenadine HCl. Am J Cardiol (1999) 1.69

Reporting guidelines for economic studies. Health Econ (1995) 1.62

Development of a composite endpoint for randomized controlled trials in liver surgery. Br J Surg (2011) 1.58

"No thank you": why elderly patients declined to participate in a research study. Pharm World Sci (2001) 1.56

Clinical and economic consequences of dyspepsia in the community. Gut (2002) 1.55

Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 1.53

Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer (2008) 1.53

Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (2000) 1.50

Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors. BMJ (1996) 1.50

Psychiatric illness and mortality after hip fracture. Lancet (2001) 1.49

The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49

Elevations of serum T3 levels and their association with symptoms in World War II veterans with combat-related posttraumatic stress disorder: replication of findings in Vietnam combat veterans. Psychosom Med (1999) 1.49

SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev (2000) 1.48

Aspirin and acute myocardial infarction: clarifying the message. Br J Gen Pract (1995) 1.48

Can Wilson's disease patients be decoppered? Lancet (1989) 1.47

CONSORT: an important step toward evidence-based health care. Consolidated Standards of Reporting Trials. Ann Intern Med (1997) 1.43

A randomized trial of Evidence-based OutReach (EBOR): rationale and design. Control Clin Trials (1999) 1.42

General practice estimates of the prevalence of common chronic conditions. Ir Med J (1992) 1.39

Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs)-what makes a NSAID good value for money? Rheumatology (Oxford) (2000) 1.38

Computerised advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev (2001) 1.38

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev (2000) 1.33

Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia (2005) 1.31

Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry. BMJ (1996) 1.30

Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int (1984) 1.29

Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 1.29

Independent predictors of revision following metal-on-metal hip resurfacing: a retrospective cohort study using National Joint Registry data. J Bone Joint Surg Br (2012) 1.26

Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project. Qual Health Care (2000) 1.26

Conventions for the reporting of nuclear magnetic shielding (or shift) tensors suggested by participants in the NATO ARW on NMR shielding constants at the University of Maryland, College Park, July 1992. Solid State Nucl Magn Reson (1993) 1.23

Valuing the effects of sildenafil in erectile dysfunction. Strong assumptions are required to generate a QALY value. BMJ (2000) 1.23

Independent predictors of failure up to 7.5 years after 35 386 single-brand cementless total hip replacements: a retrospective cohort study using National Joint Registry data. Bone Joint J (2013) 1.23

Choosing an appropriate unit of analysis in trials of interventions that attempt to influence practice. J Health Serv Res Policy (1999) 1.23

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet (2000) 1.22

The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail (2000) 1.20

Changing doctor prescribing behaviour. Pharm World Sci (1999) 1.20

Hormone profiles in humans experiencing military survival training. Biol Psychiatry (2000) 1.19

Successful laparoscopic repair of paraesophageal hernia. Arch Surg (1995) 1.18

Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction. BMJ (2000) 1.18

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16

Bicycle accidents and injuries among adult cyclists. Am J Sports Med (1986) 1.16

Late referral for dialysis: improving the management of chronic renal disease. QJM (2002) 1.15

Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev (2006) 1.14

Distribution of toxin in molluscan shellfish following the occurrence of mussel toxicity in North-East England. Nature (1968) 1.13

Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies. Am J Med (1979) 1.13

Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1. Am J Pathol (1998) 1.12

Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient. BMJ (1999) 1.11

Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm (2000) 1.10

Salmonella enteritidis in eggs from commercial chicken layer flocks implicated in human outbreaks. Avian Dis (1994) 1.10

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database Syst Rev (2007) 1.09